104 related articles for article (PubMed ID: 10460615)
1. Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation.
Ferrara F; Di Noto R; Viola A; Russo C; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Del Vecchio L
Br J Haematol; 1999 Aug; 106(2):520-3. PubMed ID: 10460615
[TBL] [Abstract][Full Text] [Related]
2. Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22).
Ferrara F; Schiavone EM; Palmieri S; Mele G; Pocali B; Scalia G; Morabito P; Sebastio L; Del Vecchio L
Hematol J; 2003; 4(3):218-21. PubMed ID: 12764355
[TBL] [Abstract][Full Text] [Related]
3. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
[TBL] [Abstract][Full Text] [Related]
4. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
Piccaluga PP; Martinelli G; Malagola M; Rondoni M; Bianchini M; Visani G; Baccarani M
Haematologica; 2003 Aug; 88(8):ECR28. PubMed ID: 12935987
[No Abstract] [Full Text] [Related]
5. The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia.
Kutlay S; Beksac M; Dalva K; Ilhan O; Koc H; Akan H; Ozcan M
Leuk Lymphoma; 2003 May; 44(5):791-5. PubMed ID: 12802915
[TBL] [Abstract][Full Text] [Related]
6. Expression of granulocyte colony-stimulating factor receptor increases with differentiation in myeloid cells by a newly-devised quantitative flow-cytometric assay.
Shinjo K; Takeshita A; Ohnishi K; Ohno R
Br J Haematol; 1995 Dec; 91(4):783-94. PubMed ID: 8547119
[TBL] [Abstract][Full Text] [Related]
7. Remission induction of refractory anaemia with excess blasts in transformation by sole treatment with granulocyte colony-stimulating factor with persistent chromosomal abnormality.
Kondo H; Kasahara Y; Mori A
Acta Haematol; 2002; 107(3):177-81. PubMed ID: 11978940
[TBL] [Abstract][Full Text] [Related]
8. G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacy.
Da Silva N; Meyer-Monard S; Menot ML; Degos L; Baruchel A; Dombret H; Chomienne C
Cytokines Cell Mol Ther; 1997 Jun; 3(2):75-80. PubMed ID: 9287246
[TBL] [Abstract][Full Text] [Related]
9. Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).
Wang Y; Li W; Chen S; Qiu H; Sun A; Wu D
Leuk Res; 2011 May; 35(5):604-7. PubMed ID: 21130493
[TBL] [Abstract][Full Text] [Related]
10. Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience.
Lee KW; Choi IS; Roh EY; Kim DY; Yun T; Lee DS; Yoon SS; Park S; Kim BK; Kim NK
Ann Hematol; 2004 Apr; 83(4):218-24. PubMed ID: 14628154
[TBL] [Abstract][Full Text] [Related]
11. Complete remission in hypoplastic acute myeloid leukemia induced by G-CSF without chemotherapy: report on three cases.
Nimubona S; Grulois I; Bernard M; Drénou B; Godard M; Fauchet R; Lamy T
Leukemia; 2002 Sep; 16(9):1871-3. PubMed ID: 12200710
[No Abstract] [Full Text] [Related]
12. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance.
Downing JR
Br J Haematol; 1999 Aug; 106(2):296-308. PubMed ID: 10460585
[No Abstract] [Full Text] [Related]
13. MPO-negative inclusions and Auer rod-like structures in a case of acute myeloid leukemia with t(8;21).
Harankhedkar S; Gupta R
Blood; 2017 Oct; 130(16):1869. PubMed ID: 29051153
[No Abstract] [Full Text] [Related]
14. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.
Katagiri T; Miyazawa K; Nishimaki J; Yaguchi M; Kawanishi Y; Ohyashiki K
Leuk Lymphoma; 2000 Sep; 39(1-2):173-84. PubMed ID: 10975397
[TBL] [Abstract][Full Text] [Related]
15. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
16. Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
Buonamici S; Ottaviani E; Visani G; Bonifazi F; Fiacchini M; Baccarani M; Martinelli G
Haematologica; 2004 Jan; 89(1):103-5. PubMed ID: 14754613
[No Abstract] [Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia.
Sallerfors B; Olofsson T
Br J Haematol; 1991 Jul; 78(3):343-51. PubMed ID: 1714757
[TBL] [Abstract][Full Text] [Related]
18. Robust in vivo differentiation of t(8;21)-positive acute myeloid leukemia blasts to neutrophilic granulocytes induced by treatment with dasatinib.
Chevalier N; Solari ML; Becker H; Pantic M; Gärtner F; Maul-Pavicic A; Hübner J; Wäsch R; Schmitt-Gräff A; Lübbert M
Leukemia; 2010 Oct; 24(10):1779-81. PubMed ID: 20811401
[No Abstract] [Full Text] [Related]
19. Forced expression of AML1-AMP19, a fusion transcript generated from a radiation-associated t(19;21) leukemia, blocks myeloid differentiation.
Ramsey H; Christopherson K; Hromas R
Leuk Res; 2004 Aug; 28(8):863-8. PubMed ID: 15203284
[TBL] [Abstract][Full Text] [Related]
20. High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia.
Schiller G; Emmanoulides C; Iastrebner MC; Lee M; Naeim F
Leuk Lymphoma; 1996 Feb; 20(5-6):427-34. PubMed ID: 8833398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
